Loss or inhibition of core c-NHEJ components, including DNA-PKcs, has been described as a mechanism of PARPi resistance in BRCA2-mutant ovarian cancer cells previously [61, 62]. The gene discussed is PRKDC; the disease is ovarian carcinoma.